Please ensure Javascript is enabled for purposes of website accessibility Horizon Pan European Mid and Large Cap Fund - Janus Henderson Investors
For individual investors in Luxembourg

Horizon Pan European Mid and Large Cap Fund


EUR 31.40
As of 12/07/2024

1-Day Change
EUR 0.13 (0.42%)
As of 12/07/2024

Morningstar Rating

As of 30/06/2024



The Fund aims to provide capital growth over the long term. Performance target: To outperform the MSCI Europe NR Index, after the deduction of charges, over any 5 year period.


The Fund invests at least 80% of its assets in shares (equities) and equity-related securities of companies, in any industry, in Europe (including UK). Companies will be located, listed or do most of their business in this region. The Fund may invest in companies of any size but will normally have a strong bias towards medium sized companies. The Fund may also invest in other assets including companies outside this region, cash and money market instruments. The Investment Manager may use derivatives (complex financial instruments) to reduce risk or to manage the Fund more efficiently. The Fund is actively managed with reference to the MSCI Europe NR Index, which is broadly representative of the companies in which it may invest, as this forms the basis of the Fund's performance target and the level above which performance fees may be charged (if applicable). The Investment Manager has discretion to choose investments for the Fund with weightings different to the index or not in the index, but at times the Fund may hold investments similar to the index.



  • Focuses on identifying contrarian quality in companies that can generate superior returns on capital employed
  • Uncovering hidden potential through comprehensive analysis, a disciplined valuation approach, and a focus on mid-cap companies
  • Differentiated portfolio construction designed to minimise factor risk with alpha driven by stock selection

The value of an investment and the income from it can fall as well as rise as a result of market and currency fluctuations and you may not get back the amount originally invested.
Potential investors must read the prospectus, and where relevant, the key investor information document before investing.
This website is a Marketing Communication and does not qualify as an investment recommendation.

Investment into the fund will acquire units / shares of the fund itself and not the underlying assets owned by the fund.


Marc Schartz, CFA

Portfolio Manager

Industry since 2004. Joined Firm in 2016.


Past performance does not predict future returns. All performance data includes both income and capital gains or losses and reflects the deduction of any ongoing charges or other fund expenses.
From 10th November 2023 the fund name, investment policy and benchmark changed. The benchmark changed from FTSE World Europe ex UK to MSCI Europe NR, however past performance shown prior to this date reflects the previous benchmark data.
Cumulative & Annualised Performance (%)
As of 30/06/2024
H2 EUR (Net) MSCI Europe NR
  Cumulative Annualised
1MO YTD 1YR 3YR 5YR 10YR Since Inception
H2 EUR (Net) -1.43 11.79 15.80 7.41 9.15 8.21 8.43
MSCI Europe NR -0.98 9.05 13.71 6.96 9.51 8.00 8.22
Calendar Year Returns (%)
As of 30/06/2024
H2 EUR (Net) MSCI Europe NR
YTD 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
H2 EUR (Net) 11.79 12.31 -7.56 23.02 2.02 24.50 -15.18 16.00 0.91 17.19 9.70
MSCI Europe NR 9.05 17.78 -11.97 25.16 2.83 27.59 -10.45 13.01 3.35 10.92 7.38
Calendar Year Returns (%)
Year H2 EUR (Net) Index
2023 12.31 17.78
2022 -7.56 -11.97
2021 23.02 25.16
2020 2.02 2.83
2019 24.50 27.59
2018 -15.18 -10.45
2017 16.00 13.01
2016 0.91 3.35
2015 17.19 10.92
2014 9.70 7.38
2013 20.23 22.04
2012 20.11 21.34
2011 from 03/02/2011 -11.50 -15.85
Initial Charge 5.00%
Annual Charge 0.60%
Ongoing Charge
(As of 30/06/2023)
Performance Fee 10% of the 'Relevant Amount'
Hurdle Rate MSCI Europe


Top Holdings (As of 30/06/2024)
% of Fund
Novo Nordisk 5.30
TotalEnergies 4.93
ASML 4.42
RELX 2.97
AstraZeneca 2.91
ASR Nederland 2.67
adidas 2.56
Unilever 2.46
Sanofi 2.36
SAP 2.34


  • The value of the Funds and the income from them is not guaranteed and may fall as well as rise. You may get back less than you originally invested.
  • Past performance does not predict future returns.
  • Third party data is believed to be reliable, but its completeness and accuracy is not guaranteed.
  • Shares/Units can lose value rapidly, and typically involve higher risks than bonds or money market instruments. The value of your investment may fall as a result.
  • Shares of small and mid-size companies can be more volatile than shares of larger companies, and at times it may be difficult to value or to sell shares at desired times and prices, increasing the risk of losses.
  • If a Fund has a high exposure to a particular country or geographical region it carries a higher level of risk than a Fund which is more broadly diversified.
  • The Fund may use derivatives with the aim of reducing risk or managing the portfolio more efficiently. However this introduces other risks, in particular, that a derivative counterparty may not meet its contractual obligations.
  • If the Fund holds assets in currencies other than the base currency of the Fund, or you invest in a share/unit class of a different currency to the Fund (unless hedged, i.e. mitigated by taking an offsetting position in a related security), the value of your investment may be impacted by changes in exchange rates.
  • When the Fund, or a share/unit class, seeks to mitigate exchange rate movements of a currency relative to the base currency (hedge), the hedging strategy itself may positively or negatively impact the value of the Fund due to differences in short-term interest rates between the currencies.
  • Securities within the Fund could become hard to value or to sell at a desired time and price, especially in extreme market conditions when asset prices may be falling, increasing the risk of investment losses.
  • The Fund could lose money if a counterparty with which the Fund trades becomes unwilling or unable to meet its obligations, or as a result of failure or delay in operational processes or the failure of a third party provider.
  • Funds incur costs as a necessary part of buying and selling the underlying investments, these are otherwise known as portfolio transaction costs, and include charges such as broker commission and Stamp Duty.
  • Before investing in any of our funds you should satisfy yourself as to the suitability and the risks involved, you may wish to consult a financial adviser.
  • If you invest through a third party provider you are advised to consult them directly as charges, performance and terms and conditions may differ materially.
  • Summary of Investor rights
  • Janus Henderson Investors Europe S.A. may decide to terminate the marketing arrangements of this Collective Investment Scheme in accordance with the appropriate regulation.
  • Information on compliance with EU Sustainability related disclosures can be found here.
  • For detailed product information including the risks associated with investing please read the relevant Prospectus or Annual Report. Please refer to the prospectus of the UCITS and to the KID before making any final investment decisions.